This is a snippet of the transcript.Contact Salesto get full access.
The key was extremely good negotiation and handling extremely high volumes. The teams did an excellent job onboarding banks or banking partners. We managed to push through massive volumes, which allowed us to secure very competitive pricing for most high-volume routes, even without netting. Towards the end, the Visa factor played a role. Since Visa owns Currencycloud, it helped in a few negotiations, maybe five or seven, where Currencycloud previously wasn't getting good pricing. Visa Payments Limited or other Visa entities were able to secure better terms. There was a harmonization project to ensure Currencycloud received similar pricing, or at least no entities were disadvantaged.
This is a snippet of the transcript.Contact Salesto get full access.
When banks consider a correspondent relationship or sale, they don't just look at Currencycloud as an entity. They consider Visa and the broader relationship with Visa. They might price Currencycloud at cost or even below cost because they are lending Visa significant amounts, like $100 million or $1 billion. They evaluate the commercial relationship as a whole rather than individually.
This is a snippet of the transcript.Contact Salesto get full access.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2025 IP 1 Ltd. All rights reserved.
Subscribe to access hundreds of interviews and primary research